# Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver

> **NCT00020501** · PHASE3 · COMPLETED · sponsor: **National Institutes of Health Clinical Center (CC)**

## Conditions studied

- Colorectal Cancer
- Metastatic Cancer

## Interventions

- **DRUG:** FOLFIRI regimen
- **DRUG:** floxuridine
- **DRUG:** fluorouracil
- **DRUG:** irinotecan hydrochloride
- **DRUG:** leucovorin calcium
- **DRUG:** melphalan
- **PROCEDURE:** hyperthermia treatment

## Key facts

- **NCT ID:** NCT00020501
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** —
- **Final completion:** 2005-01
- **Target enrollment:** — (—)
- **Last updated:** 2012-03-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00020501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00020501, "Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00020501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*